Resources

#Drug discovery

App Note: Fcγ Receptor and Antigen Kinetic Screening for Rapid Biosimilar Downstream Processing Assessment

Demonstrating similarity of biomolecules such as antibodies throughout upstream and downstream production processes is crucial. A rapid testing method is demonstrated using a Humira® biosimilar (adalimumab) development sample, which assesses compatibility with three essential ligands in compliance with regulatory standards. This Application Note covers: How to rapidly assess column… Read More

#App Notes

#Therapeutic Antibodies

App Note: Biologics developability: How Merck creates developability profiles for their mAbs with Prometheus Panta

In this Application Note, discover how the Protein Sciences group at Merck & Co. builds developability profiles for their monoclonal antibody variants.   Get an in-depth explanation of the experiments they set up to obtain parameters that help them decide which candidates have the best potential to reach the market, and how they… Read More

#App Notes

#Automation / robotics #Drug discovery

Whitepaper: Bespoke Biosafety: Building a Custom Biosafety Cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Whitepapers

#Cell Science

Whitepaper: Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages.   Download the Whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype is… Read More

#Whitepapers